CXCL12 and neoplasm: For instance, Welford et al. [24] showed that there was an increase in SDF-1- and TIE2-expressing macrophages (TEMs), a proangiogenic subset of TAMs, with CA4P treatment, suggesting that TEMs could limit the therapeutic efficacy of CA4P in tumor-bearing mice.